This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest
Exploring Nasal Casts in Nasal Drug Development
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Market Insights
Navigating the Shift to more sustainable Low GWP propellants in pMDIs
Publications, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Brand Differentiation
In Silico Modelling for Orally Inhaled Drug Development (OINDP)
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Sustainable Propellants and Bioequivalence Innovation in OINDPs
Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights